Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Endometrial Neoplasms × selinexor × Clear all

Phase

Status

Completed 3 Recruiting 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 11 Recurrence 7 Lymphoma, Large B-Cell, Diffuse 4 Sarcoma 3 Neurofibrosarcoma 2 Leukemia, Myeloid, Acute 2 Wilms Tumor 1 Vascular Neoplasms 1 Triple Negative Breast Neoplasms 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Smoldering Multiple Myeloma 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Rhabdoid Tumor 1 Ovarian Neoplasms 1 Osteosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms, Adipose Tissue 1 Myoepithelioma 1 Lymphoma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Histiocytoma, Angiomatoid Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 Granuloma, Plasma Cell 1 Granular Cell Tumor 1 Glomus Tumor 1

Interventions

pembrolizumab 24 Paclitaxel 19 Carboplatin 17 Bevacizumab 12 Specimen Handling 11 Letrozole 10 Biopsy 7 dostarlimab 6 abemaciclib 6 Taxes 6 Magnetic Resonance Spectroscopy 6 Fulvestrant 6 olaparib 5 Megestrol Acetate 5 Medroxyprogesterone Acetate 5 Drug Therapy 5 Cisplatin 5 Blood Specimen Collection 5 trastuzumab deruxtecan 4 atezolizumab 4 Radiotherapy 4 Progestins 4 Observation 4 Nivolumab 4 Immunoglobulin G 4 Doxorubicin 4 palbociclib 3 lenvatinib 3 durvalumab 3 X-Rays 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05611931 2026-02-02

XPORT-EC-042

Karyopharm Therapeutics Inc

Phase 3 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡